BridgeMD
New treatment option for Zygomatic Implant
Official title Flapless Zygomatic Implants Robot-assisted Placement
ClinicalTrials.gov ID: NCT05565157
What this study is testing
- What it's testing
- Zygomatic implants are indicated for the rehabilitation of the severely atrophic maxilla. Similar to standard implant placement, gaining an optimal position of the zygomatic implants is essential for a predictable prosthetic-driven treatment outcome.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Patients suffering from Maxillary edentulism with severe bone resorption
- Patients suffering from maxillary edentulism post maxillary defect (carcinologic or traumatic) and free flap reconstruction
- Patients suffering from post-maxillectomy buccosinusal communication.
- Age ≥ 18 years old
- Having signed the informed consent
You likely can't join if
- Patients suffering from chronic sinusitis
- Patients refusing ROSA robot-guided surgery (unsigned informed consent).
- Pregnant and nursing women
The study team makes the final eligibility decision.
Where it's taking place
- Amiens, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Amiens, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.